loader from loading.io
Therapy of Transthyretin Cardiomyopathy show art Therapy of Transthyretin Cardiomyopathy

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Therapy of Transthyretin Cardiomyopathy

info_outline
COVID-19 in Patients with Heart Disease and Cancer show art COVID-19 in Patients with Heart Disease and Cancer

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

COVID-19 in Patients with Heart Disease and Cancer

info_outline
Cardiovascular Events with CHOP/RCHOP in Non-Hogkin's  show art Cardiovascular Events with CHOP/RCHOP in Non-Hogkin's

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Cardiovascular Events with CHOP/RCHOP in Non-Hogkin's -Hot-of-the-Press

info_outline
 Cancer Risk Podcast 3 show art Cancer Risk Podcast 3

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Cancer Risk Podcast 3

info_outline
Cancer Risk Podcast 2 show art Cancer Risk Podcast 2

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Cancer Risk Podcast no 2

info_outline
Cancer Risk show art Cancer Risk

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

🎧 Cancer Risk

info_outline
Oncometabolites and The Heart show art Oncometabolites and The Heart

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Oncometabolites and The Heart

info_outline
Fasting for Chemotherapy Induced Heart Failure? show art Fasting for Chemotherapy Induced Heart Failure?

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Fasting for Chemotherapy Induced Heart Failure? |Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

info_outline
Food for Thought: Should the FDA, EMA, NCI, NHLBI, ICOS, ACC, AHA, mandate Cardio-Oncologists on Cancer Clinical Trials with Cardiotoxic Drugs?|  Trastuzumab Cardiotoxicity in DESTINY-Breast04 Trial show art Food for Thought: Should the FDA, EMA, NCI, NHLBI, ICOS, ACC, AHA, mandate Cardio-Oncologists on Cancer Clinical Trials with Cardiotoxic Drugs?| Trastuzumab Cardiotoxicity in DESTINY-Breast04 Trial

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203690#.YsoGdaAS_fY.twitter DESTINY-Changing Results for Advanced Breast Cancer | NEJM   Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks? https://www.heartfailure.theclinics.com/article/S1551-7136(11)00037-7/fulltext#.YsoHTLcs3-M.twitter Using a Magnet to Strike Gold https://www.heartfailure.theclinics.com/article/S1551-7136(09)00026-9/fulltext#.YsoG3Cq5rAs.twitter

info_outline
Long-Term Risk of Heart Failure with Trastuzumab show art Long-Term Risk of Heart Failure with Trastuzumab

Dr. Baliga's 'Got Knowledge Doc?' PODKASTS

Dr RR Baliga's Internal Medicine Podkasts for Physicians: "Got Knowledge Doc?" about Long-Term Risk of HF with Chemotherapy with Trastuzumab

info_outline
 
More Episodes
  1. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203690#.YsoGdaAS_fY.twitter
  2. DESTINY-Changing Results for Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMe2206661#.YsoGjty1ahE.twitter
     
  3. Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks? https://www.heartfailure.theclinics.com/article/S1551-7136(11)00037-7/fulltext#.YsoHTLcs3-M.twitter
  4. Using a Magnet to Strike Gold
    https://www.heartfailure.theclinics.com/article/S1551-7136(09)00026-9/fulltext#.YsoG3Cq5rAs.twitter